Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Oh

Showing results (501-510 of 552) with videos related to

Pageof 56
Sort By:
Circulation. Heart Failure|December 10, 2024
Elevated Donor-Derived Cell-Free DNA Levels Are Associated With Reduced Myocardial Blood Flow but Not Angiographic Cardiac Allograft Vasculopathy: The EVIDENT StudyCathrine M Moeller, Daniel Oren, Andrea Fernandez Valledor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2024
Plasma Proteomic Signature Predicts Myeloid Neoplasm RiskDuc Tran, J Scott Beeler, Jie Liu, et al.
Cancer Medicine|October 24, 2017
Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10-day decitabine regimenAlaa M Ali, Daniel Weisel, Feng Gao, et al.
Cell|October 23, 2018
High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer TherapyMatthew M Gubin, Ekaterina Esaulova, Jeffrey P Ward, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|February 19, 2024
Hemodynamic Optimization by Invasive Ramp Test in Patients Supported With HeartMate 3 Left Ventricular Assist DeviceGal Rubinstein, Cathrine M Moeller, Dor Lotan, et al.
Cell|November 17, 2018
High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer TherapyMatthew M Gubin, Ekaterina Esaulova, Jeffrey P Ward, et al.
British Journal of Cancer|March 2, 2013
Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201)Y-K Kang, H-M Chang, J H Yook, et al.
Future Oncology (London, England)|January 11, 2021
MOMENTUM: momelotinib vs danazol in patients with myelofibrosis previously treated with JAKi who are symptomatic and anemicSrdan Verstovsek, Chih-Cheng Chen, Miklós Egyed, et al.
NEJM Evidence|August 26, 2025
Pemigatinib for Myeloid/Lymphoid Neoplasms with <i>FGFR1</i> RearrangementSrdan Verstovsek, Jean-Jacques Kiladjian, Alessandro M Vannucchi, et al.
Haematologica|June 1, 2023
Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinibRuben Mesa, Srdan Verstovsek, Uwe Platzbecker, et al.
Pageof 56

Showing results (501-510 of 552) with videos related to

Sort By:
Pageof 56
Circulation. Heart Failure|December 10, 2024
Elevated Donor-Derived Cell-Free DNA Levels Are Associated With Reduced Myocardial Blood Flow but Not Angiographic Cardiac Allograft Vasculopathy: The EVIDENT StudyCathrine M Moeller, Daniel Oren, Andrea Fernandez Valledor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2024
Plasma Proteomic Signature Predicts Myeloid Neoplasm RiskDuc Tran, J Scott Beeler, Jie Liu, et al.
Cancer Medicine|October 24, 2017
Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10-day decitabine regimenAlaa M Ali, Daniel Weisel, Feng Gao, et al.
Cell|October 23, 2018
High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer TherapyMatthew M Gubin, Ekaterina Esaulova, Jeffrey P Ward, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|February 19, 2024
Hemodynamic Optimization by Invasive Ramp Test in Patients Supported With HeartMate 3 Left Ventricular Assist DeviceGal Rubinstein, Cathrine M Moeller, Dor Lotan, et al.
Cell|November 17, 2018
High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer TherapyMatthew M Gubin, Ekaterina Esaulova, Jeffrey P Ward, et al.
British Journal of Cancer|March 2, 2013
Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201)Y-K Kang, H-M Chang, J H Yook, et al.
Future Oncology (London, England)|January 11, 2021
MOMENTUM: momelotinib vs danazol in patients with myelofibrosis previously treated with JAKi who are symptomatic and anemicSrdan Verstovsek, Chih-Cheng Chen, Miklós Egyed, et al.
NEJM Evidence|August 26, 2025
Pemigatinib for Myeloid/Lymphoid Neoplasms with <i>FGFR1</i> RearrangementSrdan Verstovsek, Jean-Jacques Kiladjian, Alessandro M Vannucchi, et al.
Haematologica|June 1, 2023
Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinibRuben Mesa, Srdan Verstovsek, Uwe Platzbecker, et al.
Pageof 56